PyInvesting

Market research

AMRUTANJAN.NSE Amrutanjan Health Care Limited

NSE INR Healthcare

Latest close

512.65 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
15B
P/E ratio
28.02
Analyst target
Not available
Dividend yield
0.0%
Beta
0.42

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Amrutanjan Health Care Limited is currently in a long term uptrend where the price is trading 26.2% above its 200 day moving average.

From a valuation standpoint, the stock is 21.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 5.8.

Amrutanjan Health Care Limited's total revenue rose by 21.0% to $1B since the same quarter in the previous year.

Its net income has increased by 121.1% to $210M since the same quarter in the previous year.

Finally, its free cash flow grew by 696.5% to $655M since the same quarter in the previous year.

Based on the above factors, Amrutanjan Health Care Limited gets an overall score of 4/5.